Perrigo (PRGO) Current Assets (2013 - 2026)
Perrigo's (PRGO) quarterly Current Assets came in at $2.7 billion in Q1 2026, up 7.08% year-on-year from $2.5 billion in Q1 2025, and down 3.04% on a QoQ basis from $2.8 billion in Q4 2025.
Perrigo (PRGO) Current Assets (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Current Assets data on file, last reported at $2.7 billion in Q1 2026.
- On a quarterly basis, Current Assets rose 7.08% year-over-year to $2.7 billion in Q1 2026; TTM through Mar 2026 was $2.7 billion, a 7.08% increase from a year earlier, with the FY2025 full-year figure at $2.8 billion, up 12.71% from the prior year.
- Current Assets for Q1 2026 stood at $2.7 billion, down from $2.8 billion in the prior quarter.
- Over the last five years, Current Assets for PRGO reached as high as $3.9 billion in Q2 2022 and fell as low as $2.5 billion in Q4 2024.
- Historically, Current Assets has averaged $2.9 billion across 5 years, with a median of $2.8 billion in 2023.
- Across the five-year window, Current Assets tumbled 40.01% in 2022 and soared 34.08% in 2024, its largest moves.
- Year by year, Current Assets stood at $2.7 billion in 2022, then increased by 4.15% to $2.8 billion in 2023, then slipped by 12.39% to $2.5 billion in 2024, then gained by 12.71% to $2.8 billion in 2025, then retreated by 3.04% to $2.7 billion in 2026.
- Per Business Quant data, the three most recent Current Assets figures were $2.7 billion in Q1 2026, $2.8 billion in Q4 2025, and $2.9 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 6.05 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 13.71 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 6.47 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 19.71 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 2.87 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 53.60 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 10.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.44 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.58 Bn |
| 10 | Perrigo | 1.40 Bn | 1.05 Bn | 325.50 Mn | 2.71 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2.71 Bn |
| Dec 31, 2025 | 2.80 Bn |
| Sep 27, 2025 | 2.88 Bn |
| Jun 28, 2025 | 2.62 Bn |
| Mar 29, 2025 | 2.53 Bn |
| Dec 31, 2024 | 2.48 Bn |
| Sep 28, 2024 | 3.71 Bn |
| Jun 29, 2024 | 2.96 Bn |
| Mar 30, 2024 | 2.81 Bn |
| Dec 31, 2023 | 2.83 Bn |
| Sep 30, 2023 | 2.77 Bn |
| Jul 1, 2023 | 2.77 Bn |
| Apr 1, 2023 | 2.74 Bn |
| Dec 31, 2022 | 2.72 Bn |
| Oct 1, 2022 | 2.58 Bn |
| Jul 2, 2022 | 2.65 Bn |
| Apr 2, 2022 | 3.94 Bn |
| Dec 31, 2021 | 3.86 Bn |
| Oct 2, 2021 | 4.23 Bn |
| Jul 3, 2021 | 4.42 Bn |